Efficacy And Safety Of Glecaprevir/Pibrentasvir Treatment For 8 Weeks In Treatment-Naive Patients With Chronic Hepatitis C Virus Infection Without Cirrhosis Or With Compensated Cirrhosis: Analysis Of Data Pooled From Phase 2 And 3 Studies
GASTROENTEROLOGY（2019）
关键词
glecaprevir/pibrentasvir treatment,compensated cirrhosis,hepatitis,treatment-naive
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要